[1]
“EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES”, Mediterr J Hematol Infect Dis, vol. 3, no. 1, p. e2011020, May 2011, doi: 10.4084/mjhid.2011.020.